These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23938353)

  • 1. Myasthenia gravis: new therapeutic approaches based on pathophysiology.
    Lewis RA
    J Neurol Sci; 2013 Oct; 333(1-2):93-8. PubMed ID: 23938353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis: emerging new therapy options.
    Sieb JP
    Curr Opin Pharmacol; 2005 Jun; 5(3):303-7. PubMed ID: 15907918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myasthenia gravis].
    Fleury MC; Tranchant C
    Rev Prat; 2008 Dec; 58(20):2217-24. PubMed ID: 19209651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome after Robotic-Assisted Thymectomy in Children and Adolescents with Acetylcholine Receptor Antibody-Positive Juvenile Myasthenia Gravis.
    Della Marina A; Kölbel H; Müllers M; Kaiser O; Ismail M; Swierzy M; Rueckert JC; Schara U
    Neuropediatrics; 2017 Aug; 48(4):315-322. PubMed ID: 28628938
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab in the management of refractory myasthenia gravis.
    Zebardast N; Patwa HS; Novella SP; Goldstein JM
    Muscle Nerve; 2010 Mar; 41(3):375-8. PubMed ID: 19852027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior damage to lower motor neuron triggering myasthenia gravis.
    Steiner I; Goldstein L; Hellmann MA; Lotan I
    Muscle Nerve; 2016 Jun; 54(1):167-9. PubMed ID: 26789735
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of novel therapies for MG: Studies in animal models.
    Souroujon MC; Brenner T; Fuchs S
    Autoimmunity; 2010 Aug; 43(5-6):446-60. PubMed ID: 20298126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis crisis.
    Bershad EM; Feen ES; Suarez JI
    South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of myasthenia gravis.
    Arora Y; Li Y
    Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: immunological mechanisms and immunotherapy.
    Lewis RA; Selwa JF; Lisak RP
    Ann Neurol; 1995 May; 37 Suppl 1():S51-62. PubMed ID: 8968217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
    Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
    Saulat B; Maertens P; Hamilton WJ; Bassam BA
    Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.
    Lagoumintzis G; Zisimopoulou P; Kordas G; Lazaridis K; Poulas K; Tzartos SJ
    Autoimmunity; 2010 Aug; 43(5-6):436-45. PubMed ID: 20187712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future therapies for myasthenia gravis.
    Yi Q; Lefvert AK
    Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.